ArticleBMC cancer2024
p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.
Abdulkader Yassin-Kassab et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it